Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1997
03/13/1997WO1997009439A1 Methods and vectors for site-specific recombination
03/13/1997WO1997009438A1 Process for modifying glucose repression
03/13/1997WO1997009437A1 Materials and methods relating to the attachment and display of substances on cell surfaces
03/13/1997WO1997009436A1 Method for producing phage display vectors
03/13/1997WO1997009435A1 Plasmid stabilization
03/13/1997WO1997009434A1 Dna structure-specific nucleases
03/13/1997WO1997009433A1 Cell-cycle checkpoint genes
03/13/1997WO1997009432A1 Cyclin-dependent kinase
03/13/1997WO1997009431A1 Blue copper oxidase mutants with enhanced activity
03/13/1997WO1997009429A2 Compounds and methods for diagnosis of tuberculosis
03/13/1997WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997WO1997009427A1 Vegf-related protein
03/13/1997WO1997009426A1 Rna polymerase transcription factor
03/13/1997WO1997009425A1 Cerebellum-derived growth factors, and uses related thereto
03/13/1997WO1997009422A1 Overexpression of recombinant bacteriophage t4 endonuclease vii and uses thereof
03/13/1997WO1997009420A2 Dna sequences coding for a human metalloproteinase and variants thereof
03/13/1997WO1997009419A1 Monoclonal lymphocytes and methods of use
03/13/1997WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
03/13/1997WO1997009417A1 Control of leaf scald disease
03/13/1997WO1997009353A1 A device for the synthesis of compounds in an array
03/13/1997WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997WO1997009349A1 Binding protein
03/13/1997WO1997009348A2 Orphan receptor
03/13/1997WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/13/1997WO1997009342A1 Screen for compounds with affinity for rna
03/13/1997WO1997009337A1 Metallocene-phosphoramidite conjugates, process for their preparation and their use
03/13/1997WO1997009070A1 Glucocorticoid enhancement of gene expression
03/13/1997WO1997009064A1 Use of muteins of wild-type cytokines as immunogens
03/13/1997WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins
03/13/1997WO1997008955A1 Bacterial delivery system
03/13/1997WO1997008947A1 Transformant
03/13/1997WO1997008944A1 Recombinant chitinase and use thereof as a biocide
03/13/1997WO1997006268A3 Dna constructs
03/13/1997WO1997006267A3 Genetic transformation using a parp inhibitor
03/13/1997WO1997006261A3 The use of homologous amds genes as selectable markers
03/13/1997WO1997005256A3 Mammalian pro-hormone convertase
03/13/1997WO1997005170A3 Broad specificity antibodies
03/13/1997WO1997003345A3 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna
03/13/1997WO1997003205A3 Novel dna sequences and their use for identifying defence-inducing agents in plants
03/13/1997WO1997003089A3 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin a and b chains
03/13/1997WO1996039500A3 Oligonucleotides specific for hepatitis c virus
03/13/1997WO1996034964A3 Stable variant hk2 polypeptide
03/13/1997WO1996033279A3 Repertoire cloning process, products derived therefrom and uses for said products
03/13/1997WO1996028562A3 Method of checking undesired multiplication of viruses and of preparing virus-resistant organisms
03/13/1997CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997CA2231788A1 Targeted nucleotide sequence delivery and integration system
03/13/1997CA2231400A1 Vegf-related protein
03/13/1997CA2231372A1 Materials and methods relating to the attachment and display of substances on cell surfaces
03/13/1997CA2231190A1 Cell-cycle checkpoint genes
03/13/1997CA2231182A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997CA2231170A1 A device for the synthesis of compounds in an array
03/13/1997CA2231045A1 Method for producing phage display vectors
03/13/1997CA2230927A1 Compounds and methods for diagnosis of tuberculosis
03/13/1997CA2230893A1 Identification of bases in nucleic acid sequences
03/13/1997CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
03/13/1997CA2230758A1 Improved aav vectors for gene therapy
03/13/1997CA2230593A1 Rna polymerase transcription factor
03/13/1997CA2230388A1 Detection of mismatches by resolvase cleavage using a magnetic bead support
03/13/1997CA2230384A1 Methods and vectors for site-specific recombination
03/13/1997CA2230099A1 Overexpression of recombinant bacteriophage t4 endonuclease vii and uses thereof
03/13/1997CA2229345A1 Glucocorticoid enhancement of gene expression
03/13/1997CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/13/1997CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins
03/13/1997CA2227301A1 Hcv binding protein
03/13/1997CA2203832A1 Screen for compounds with affinity for rna
03/13/1997CA2185379A1 Method for serial analysis of gene expression
03/12/1997EP0761822A2 Method for serial analysis of gene expression
03/12/1997EP0761816A2 Process for the enhancement of seed production and plant growth through the addition of plastidal pyruvate phosphate dikinase
03/12/1997EP0761815A2 Bacillus thuringiensis sporulation gene
03/12/1997EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces
03/12/1997EP0761687A1 Process for preparing antibody
03/12/1997EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta)
03/12/1997EP0761233A2 Transkaryotic implantation
03/12/1997EP0761231A1 Vaccine composition containing adjuvants
03/12/1997EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch
03/12/1997EP0760867A1 Compositions and methods relating to dna mismatch repair genes
03/12/1997EP0760864A1 Dna encoding glutamate gated chloride channels
03/12/1997EP0760861A1 An autonomous replication system for mammalian cells
03/12/1997EP0760860A1 Methods of in vivo gene delivery
03/12/1997EP0760859A1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
03/12/1997EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
03/12/1997EP0760857A1 Receptor for oncostatin m
03/12/1997EP0760856A1 Microorganisms permitting the intracellular polyhydroxy alkanoate synthesis with simultaneous extracellular polysaccharide synthesis and processes for producing the same
03/12/1997EP0760855A1 Hepatitis c virus asialoglycoproteins
03/12/1997EP0760854A1 Lag1: a gene for increasing the longevity of eukaryotes
03/12/1997EP0760853A1 Methods and associated reagents for detecting modulators of cytokine action
03/12/1997EP0760852A1 Immunosuppressant target proteins
03/12/1997EP0760851A1 Tumor necrosis factor receptor-associated factors
03/12/1997EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY)
03/12/1997EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN
03/12/1997EP0760682A1 Gene transfer-mediated angiogenesis therapy
03/12/1997EP0760675A1 Compositions comprising dna damaging agents and p53
03/12/1997EP0760602A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
03/12/1997EP0708828B1 Obtaining nucleic acids
03/12/1997EP0644774A4 Improved production of reproductive hormones.
03/12/1997EP0636137B1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
03/12/1997EP0627001A4 Mammalian sos - a regulator/effector of tyrosine kinase signalling.
03/12/1997EP0367767B1 Bacillus thuringiensis p-2 toxin gene, protein and related insecticide compositions
03/12/1997CN1145098A Comparative gene transcript analysis